NCT07199764 2026-03-06
IGNITE
University of Pennsylvania
Phase 2 Recruiting
Clinical Trials
8 trialsNCT05289830 2025-12-10
Escitalopram to Placebo in Patients With Localized Pancreatic Cancer
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT03374852 2025-04-29
CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer
Thomas Jefferson University
Phase 2 Withdrawn
NCT06467565 2024-06-21
NALIRIFOX as Induction Therapy in LAPC
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
NCT04134468 2020-01-31
MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma
Abramson Cancer Center at Penn Medicine
Phase 2 Withdrawn
NCT02926183 2019-10-03
Study of NAC of GA Therapy for Patients With BRPC
Wakayama Medical University
Phase 2 Unknown
NCT02440958 2019-02-18
Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial
Yonsei University
Phase 2 Completed
NCT03316326 2017-10-20
S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer
National Taiwan University Hospital
Phase 2 Unknown